Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 15 versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 15 versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
MANNITOL 15% vs OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Increases plasma osmolality, drawing water from intracellular and interstitial spaces into the vascular compartment, thereby reducing intracranial pressure and intraocular pressure. Acts as an osmotic diuretic in the kidneys, increasing urine flow by inhibiting water reabsorption in the proximal tubule and loop of Henle.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal tubular osmotic pressure, thereby inhibiting water reabsorption and promoting diuresis.
1-2 g/kg as a 15% solution intravenously over 30-60 minutes. Typical adult dose: 100-200 g (667-1333 mL of 15% solution) administered as a single dose for reduction of intracranial pressure or promotion of diuresis.
0.25-1 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours if needed.
None Documented
None Documented
Terminal elimination half-life approximately 0.25-1.5 hours in normal renal function; prolonged to 24-36 hours in renal impairment.
Terminal elimination half-life is 0.25–1.5 hours in normal renal function; prolonged to 4–6 hours with anuria or oliguria. Clinically, osmotic diuresis lasts as long as urine output sustains concentration.
Primarily renal (90-100% as unchanged drug); negligible biliary/fecal elimination.
Primarily renal (90-100% unchanged) via glomerular filtration; <3% metabolized in liver; minimal biliary/fecal excretion.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic